The relationship between antibodies for the novel coronavirus (SARS-CoV-2) and immunity, vaccine efficacy, and spread of COVID-19 has received significant attention. Dr. Seheult is back to illustrate why T cells have received less attention than antibodies, but may be more important to long term immunity from COVID-19. Dr. Seheult also discusses how previous infections with common coronaviruses may provide some immunity to SARS-CoV-2, and the hypothesis that reducing the inoculum (initial dose) of SARS-CoV-2 might result in less symptom severity

Links / References:

5-Minute Sharable Video About At-Home Rapid Tests | https://www.medcram.com/courses/antig…

Johns Hopkins Tracker | https://coronavirus.jhu.edu/map.html

Worldometer | https://www.worldometers.info/coronav…

CNBC | https://www.cnbc.com/2020/08/07/coron…

Clinical Infectious Diseases | https://academic.oup.com/cid/advance-…

Cell | https://www.cell.com/cell/fulltext/S0…

Washington Post | https://www.washingtonpost.com/health… 

Nature | https://www.nature.com/articles/s4159…

Journal of General Internal Medicine (Reducing inoculum) | https://link.springer.com/article/10….

CDC | https://www.cdc.gov/mmwr/volumes/69/w…

NPR | https://www.npr.org/sections/health-s…

New York Times | https://www.nytimes.com/2018/09/21/we…

THE MEDCRAM WEBSITE: Visit for videos on over 60 medical topics and CME / CEs for medical professionals: https://www.medcram.com

SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL: https://www.youtube.com/user/MEDCRAMv…

 

News

A DNA-based nanogel for targeted chemotherapy

Current chemotherapy regimens slow cancer progression and save lives, but these powerful drugs affect both healthy and cancerous cells. Now, researchers reporting in ACS' Nano Letters have designed DNA-based nanogels that only break down and [...]